Baudax Bio, Inc. (42)
Browse by Contract Category
Contracts
-
Form of Award Agreement for Restricted Stock Unit Inducement Award
(Filed With SEC on February 16, 2021)
-
Form of Award Agreement for Option Inducement Award
(Filed With SEC on February 16, 2021)
-
Form of Performance-Based Restricted Stock Unit Award Agreement
(Filed With SEC on February 16, 2021)
-
Third Amendment to License Agreement, dated August 17, 2020, by and among Alkermes Pharma Ireland Limited, Recro Gainesville LLC and Baudax Bio, Inc
(Filed With SEC on August 21, 2020)
-
Sales Agreement, dated February 13, 2020, by and between Baudax Bio, Inc. and JMP Securities LLC
(Filed With SEC on February 13, 2020)
-
Form of Restricted Stock Unit Award Agreement
(Filed With SEC on February 16, 2021)
-
Form of Stock Option Award Agreement
(Filed With SEC on February 16, 2021)
-
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on February 16, 2021)
-
Form of Securities Purchase Agreement
(Filed With SEC on February 9, 2021)
-
Form of Placement Agent Warrant
(Filed With SEC on February 9, 2021)
-
Form of Warrant
(Filed With SEC on January 22, 2021)
-
Form of Placement Agent Warrant
(Filed With SEC on January 22, 2021)
-
Form of Letter Agreement
(Filed With SEC on January 22, 2021)
-
Form of Securities Purchase Agreement
(Filed With SEC on December 18, 2020)
-
Form of Placement Agent Warrant
(Filed With SEC on December 18, 2020)
-
Form of Series B Warrant
(Filed With SEC on December 18, 2020)
-
Form of Series A Warrant
(Filed With SEC on December 18, 2020)
-
Form of Securities Purchase Agreement
(Filed With SEC on November 24, 2020)
-
Form of Placement Agent Warrant
(Filed With SEC on November 24, 2020)
-
Form of Series B Warrant
(Filed With SEC on November 24, 2020)
-
Form of Series A Warrant
(Filed With SEC on November 24, 2020)
-
Form of Warrant Exchange Agreement
(Filed With SEC on October 20, 2020)
-
Third Amendment to the Purchase and Sale Agreement, dated August 17, 2020 by and among Alkermes Pharma Ireland Limited, Daravita Limited, Alkermes US Holdings, Inc. and Baudax...
(Filed With SEC on August 21, 2020)
-
Intellectual Property Security Agreement, dated as of May 29, 2020, by and among the Company, Baudax Bio N.A. LLC, Baudax Bio Limited and Wilmington Trust, National Association
(Filed With SEC on June 2, 2020)
-
Security Agreement, dated as of May 29, 2020, by and among the Company, Baudax Bio N.A. LLC, Baudax Bio Limited and Wilmington Trust, National Association
(Filed With SEC on June 2, 2020)
-
Credit Agreement, dated as of May 29, 2020, among the Company, the lenders party thereto and Wilmington Trust, National Association
(Filed With SEC on June 2, 2020)
-
Common Stock Purchase Warrant, dated May 29, 2020, in favor of MAM Eagle Lender, LLC
(Filed With SEC on June 2, 2020)
-
Note dated May 8, 2020, between Baudax Bio, Inc. and PNC Bank, National Association
(Filed With SEC on May 13, 2020)
-
Description of Securities
(Filed With SEC on May 8, 2020)
-
Underwriting Agreement, dated March 24, 2020, by and between Baudax Bio, Inc. and JMP Securities LLC, as representative of the several underwriters named therein
(Filed With SEC on March 24, 2020)
-
Form of Series B Warrant
(Filed With SEC on March 24, 2020)
-
Form of Series A Warrant
(Filed With SEC on March 24, 2020)
-
Amendment to Employee Matters Agreement, dated February 12, 2020, by and between Recro Pharma, Inc. and Baudax Bio, Inc. . 10.29 Sales Agreement, dated February 13, 2020, by and...
(Filed With SEC on February 13, 2020)
-
Employment Agreement, dated February 12, 2020, between Baudax Bio, Inc. and Ryan D. Lake
(Filed With SEC on February 13, 2020)
-
Employment Agreement, dated February 12, 2020, between Baudax Bio, Inc. and Gerri Henwood
(Filed With SEC on February 13, 2020)
-
Amendment to License Agreement, dated October 21, 2019, by and between Cornell University and Recro Pharma, Inc
(Filed With SEC on February 13, 2020)
-
Employee Matters Agreement, dated as of November 20, 2019, by and between Recro Pharma, Inc. and Baudax Bio, Inc
(Filed With SEC on November 26, 2019)
-
Tax Matters Agreement, dated as of November 20, 2019, by and between Recro Pharma, Inc. and Baudax Bio, Inc
(Filed With SEC on November 26, 2019)
-
Transition Services Agreement, dated as of November 20, 2019, by and between Recro Pharma, Inc. and Baudax Bio, Inc
(Filed With SEC on November 26, 2019)
-
Baudax Bio, Inc. 2019 Equity Incentive Plan
(Filed With SEC on November 26, 2019)
-
Assignment, Assumption and Bifurcation Agreement, dated November 20, 2019, by and among Alkermes Pharma Ireland Limited, Recro Gainesville LLC, Recro Pharma, Inc. and Baudax Bio,...
(Filed With SEC on November 26, 2019)
-
Separation Agreement, dated as of November 20, 2019, by and between Recro Pharma, Inc. and Baudax Bio, Inc
(Filed With SEC on November 26, 2019)
